Piccina Cintia
Insider CIK 1907199 · ADAP Chief Commercial Officer · AUTL U.S. CCO & Country Gen Manager · ALVR Chief Commercial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AUTL Autolus Therapeutics plc | S Sale | 2026-09-02 | 2026-09-03 | 6,713 | $2.34 | $15.7K | 13,287 | SEC↗ |
| AUTL Autolus Therapeutics plc | S Sale | 2026-09-02 | 2026-09-03 | 6,713 | $2.34 | $15.7K | 13,287 | SEC↗ |
| AUTL Autolus Therapeutics plc | M Exercise deriv | 2026-09-01 | 2026-09-03 | 20,000 | — | $0 | 60,000 | SEC↗ |
| AUTL Autolus Therapeutics plc | M Exercise | 2026-09-01 | 2026-09-03 | 20,000 | $2.35 | $47.0K | 20,000 | SEC↗ |
| AUTL Autolus Therapeutics plc | M Exercise deriv | 2026-09-01 | 2026-09-03 | 20,000 | — | $0 | 60,000 | SEC↗ |
| AUTL Autolus Therapeutics plc | M Exercise | 2026-09-01 | 2026-09-03 | 20,000 | $2.35 | $47.0K | 20,000 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2025-02-20 | 2025-02-20 | 1,074,696 | — | $0 | 1,074,696 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2025-02-20 | 2025-02-20 | 1,612,032 | — | $0 | 1,612,032 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2025-01-15 | 2025-01-15 | 12,991 | $0.57 | $7.4K | 18,421 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2024-06-18 | 2024-06-18 | 24,531 | $0.93 | $22.8K | 38,293 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2024-03-18 | 2024-03-18 | 5,088,864 | — | $0 | 5,088,864 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2024-03-18 | 2024-03-18 | 1,130,832 | — | $0 | 1,130,832 | SEC↗ |
| ALVR Allovir, Inc. | A Award deriv | 2023-07-03 | 2023-07-05 | 273,000 | — | $0 | 273,000 | SEC↗ |
| ALVR Allovir, Inc. | A Award | 2023-07-03 | 2023-07-05 | 147,000 | — | $0 | 147,000 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2023-01-31 | 2023-01-31 | 11,890 | $1.87 | $22.2K | 19,535 | SEC↗ |
| ADAP] Adaptimmune Therapeutics P | A Award deriv | 2023-01-17 | 2023-01-17 | 314,256 | — | $0 | 314,256 | SEC↗ |
| ADAP] Adaptimmune Therapeutics P | A Award deriv | 2023-01-17 | 2023-01-17 | 181,560 | — | $0 | 181,560 | SEC↗ |
| ADAP] Adaptimmune Therapeutics P | A Award deriv | 2023-01-17 | 2023-01-17 | 1,407,072 | — | $0 | 1,407,072 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | S Sale | 2022-08-01 | 2022-08-01 | 21,040 | $1.77 | $37.2K | 34,824 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2022-01-31 | 2022-01-31 | 335,184 | — | $0 | 335,184 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2022-01-31 | 2022-01-31 | 3,376,992 | — | $0 | 3,376,992 | SEC↗ |
| ADAP Adaptimmune Therapeutics P | A Award deriv | 2022-01-31 | 2022-01-31 | 754,200 | — | $0 | 754,200 | SEC↗ |